mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.003 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.004 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |